|Articles|January 18, 2022
Process Impurities Clearance in Biologics
Author(s)Element
This white paper discusses developing optimal platform analytical methods with partner CDMOs for effective process impurities clearance in biological drug substances.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
2
Peptide Compounding Vote Raises New Questions for Drug Developers
3
Midyear 2026 Check in: Abzena’s Campbell Bunce on Trends in Antibody Drug Conjugates
4
Midyear 2026 Check-In: AI Investment Skipped Pharma's Costliest Operational Problem
5